phenylalanine has been researched along with Blood Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvfors, C; Berglund, Å; Gullbo, J; Hagberg, H; Harmenberg, J; Jerling, M; Lewensohn, R; Lisyanskaya, A; Nordström, E; Nygren, P; Orlov, S; Ringbom, M; Söderlind, K; Spira, J; Tholander, B; Ullén, A | 1 |
| Hsia, DY; Justice, P; O'Flynn, ME | 1 |
| Kolarz, G; Pietschmann, H | 1 |
| O'Gorman Hughes, DW | 1 |
| Snyder, MJ; Woodward, TE | 1 |
| Arnstein, HR; Nolan, RD | 1 |
1 review(s) available for phenylalanine and Blood Diseases
| Article | Year |
|---|---|
The clinical use of chloramphenicol.
Topics: Anemia, Aplastic; Chemical Phenomena; Chemistry; Chloramphenicol; Eye Diseases; Female; Hematologic Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infections; Melioidosis; Phenylalanine; Pregnancy; Respiratory Tract Infections; Rickettsia Infections; Salmonella Infections; Sepsis; Tularemia | 1970 |
1 trial(s) available for phenylalanine and Blood Diseases
| Article | Year |
|---|---|
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies.
Topics: Adult; Aged; Aged, 80 and over; Alkylation; Antineoplastic Agents, Alkylating; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Male; Melphalan; Middle Aged; Neoplasms; Peptide Hydrolases; Phenylalanine; Prospective Studies | 2015 |
4 other study(ies) available for phenylalanine and Blood Diseases
| Article | Year |
|---|---|
Phenylalanine-hydroxylase activity in hyperphenylalaninaemia.
Topics: Adolescent; Adult; Diagnosis, Differential; Diet Therapy; Female; Hematologic Diseases; Humans; Infant; Male; Mixed Function Oxygenases; Phenylalanine; Phenylketonurias | 1967 |
[Measurement of neutral peptidase activity in leukocyte homogenate with carboxypropionylphenylalanine-p-nitranilide substrate].
Topics: Adolescent; Adult; Aged; Anilides; Chymotrypsin; Clinical Enzyme Tests; Diagnosis, Differential; Hematologic Diseases; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Leukocyte Count; Leukocytes; Methods; Middle Aged; Nitro Compounds; Peptide Hydrolases; Phenylalanine | 1973 |
Studies on chloramphenicol. II. Possible determinants and progress of haemopoietic toxicity during chloramphenicol therapy.
Topics: Adolescent; Age Factors; Agranulocytosis; Child; Child, Preschool; Chloramphenicol; Erythrocyte Count; Hematologic Diseases; Hematopoiesis; Humans; Infant; Iron; Neutrophils; Phenylalanine; Prognosis; Reticulocytes; Riboflavin; Thrombocytopenia; Vitamin B Complex | 1973 |
The dissociation of rabbit reticulocyte ribosomes into subparticles active in protein synthesis.
Topics: Animals; Blood Proteins; Buffers; Carbon Isotopes; Cell-Free System; Centrifugation, Density Gradient; Erythrocyte Count; Fluorides; Hematologic Diseases; In Vitro Techniques; Magnesium; Osmolar Concentration; Peptide Biosynthesis; Phenylalanine; Phenylhydrazines; Polynucleotides; Potassium Chloride; Rabbits; Reticulocytes; Ribosomes; Salts; Stimulation, Chemical; Uracil Nucleotides | 1969 |